Merit Financial Group »

Aldeyra Therapeutics shares owned by Merit Financial Group

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $36k 17k 2.13
2026-03-31 $33k 20k 1.69

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p Us Gwt (IUSG)
Apple Put Option (AAPL)
Gmo Etf Trust Us Quality Etf (QLTY)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard World Mega Grwth Ind (MGK)
Blackrock Etf Trust Ishares Us Equit (DYNF)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard World Mega Cap Val Etf (MGV)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation Put Option (NVDA)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Isha In Ctry Etf (CORO)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Merit Financial Group

Top funds holding Aldeyra Therapeutics

Knoll Capital Management
BlackRock
AQR Capital Management
Vanguard Capital Management
Kingdon Capital Management
683 Capital Management
D. E. Shaw & Co
Ardsley Advisory Partners
Geode Capital Management
Jane Street
State Street Corporation
Millennium Management
Renaissance Technologies
Acadian Asset Management
Vanguard Portfolio Management

View all funds holding Aldeyra Therapeutics